171 results on '"Terenzi, Adelmo"'
Search Results
2. Haploidentical age-adapted myeloablative transplant and regulatory and effector T cells for acute myeloid leukemia
3. T cell depletion and no post transplant immune suppression allow separation of graft versus leukemia from graft versus host disease
4. Haploidentical hematopoietic transplantation from KIR ligand–mismatched donors with activating KIRs reduces nonrelapse mortality
5. HLA-Matched Treg/Tcon Allogeneic Hematopoietic Cell Transplantation Is Safe and Ensures Remarkable Chronic GvHD/Leukemia Free Survival in High-Risk Leukemia Patients
6. “Designed” grafts for HLA-haploidentical stem cell transplantation
7. New mechanism of lymphoma-induced bone marrow aplasia
8. Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation
9. Immunoselection and clinical use of T regulatory cells in HLA-haploidentical stem cell transplantation
10. Acute GvHD after HLA-Haploidentical Hematopoietic Cell Transplantation with Regulatory and Conventional T Cell Immunotherapy Does Not Adversely Affect Transplantation Outcomes
11. Activated autologous T cells exert an anti-B-cell chronic lymphatic leukemia effect in vitro and in vivo
12. Enhancement of Bone Marrow Allografts from Nude Mice into Mismatched Recipients by T Cells Void of Graft-Versus-Host Activity
13. Large-scale generation of human allodepleted anti-3rd party lymphocytes
14. Homing and survival of thymidine kinase-transduced human T cells in NOD/SCID mice
15. T-lymphocyte function after retroviral-mediated thymidine kinase gene transfer and G418 selection
16. Regulatory T Cell Adoptive Immunotherapy Promotes B Cell Immunity after Haploidentical Transplantation
17. Absidia corymbifera necrotizing cellulitis in an immunocompromised patient while on voriconazole treatment
18. Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype
19. Full Haplotype-Mismatched Hematopoietic Stem-Cell Transplantation: A Phase II Study in Patients With Acute Leukemia at High Risk of Relapse
20. Treg/Tcon Immunotherapy and High Dose Marrow Irradiation Ensure Full Control of Leukemia Relapse in Haploidentical Transplantation
21. How Adoptive Immunotherapy with Conventional T and Regulatory T Cells Exerts a Gvl Effect without GvHD, after Haploidentical Hematopoietic Transplantation
22. Haploidentical Transplantation with Regulatory and Conventional T Cells Improves Outcome of Patients Affected By Acute Myeloid Leukemia with Complex Karyotype and/or Monosomy 7/Del(7q)
23. Evaluation of immunotoxins containing single-chain ribosome-inactivating proteins and an anti-CD22 monoclonal antibody (OM124): in vitro and in vivo studies
24. Anti-CD30 (BER-H2) immunotoxins containing the type-1 ribosome-inactivating proteins momordin and PAP-S (pokeweed antiviral protein from seeds) display powerful antitumour activity against CD30+ tumour cells in vitro and in SCID mice
25. Absidia Corymbifera in an immune competent accident victim with multiple abdominal injuries: case report
26. An Accelerated CD8+, but Not CD4+, T-Cell Reconstitution Associates with a More Favorable Outcome Following HLA-Haploidentical HSCT: Results from a Retrospective Study of the Cell Therapy and Immunobiology Working Party of the EBMT
27. Quality of life and physicians' perception in myelodysplastic syndromes
28. Tregs Suppress GvHD at the Periphery and Unleash the Gvl Effect in the Bone Marrow
29. HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse
30. HLA-Haploidentical Stem Cell Transplantation with Treg and Tcon Adoptive Immunotherapy promotes a Strong Graft-Versus-Leukemia Effect
31. Decitabine In Advanced Chronic Myelomonocytic Leukemia
32. Adoptive Immunotherapy with Tregs and Tcons Ensures Low TRM and a Low Incidence of Post Transplant Leukaemia Relapse After HLA Haploidentical Transplants for Acute Leukemia
33. Adoptive Immunotherapy with Tregs Prevents GvHD and Favours Immune Reconstitution After HLA Haploidentical Transplants for Hematological Malignancies.
34. Quality of Life in Myelodysplastic Syndromes and Physicians' Perception.
35. Quality of Life Assessment in Patients Affected by Myelodysplastic Syndrome
36. T Cell Pathway Deficiencies in Chronic Lymphocityc Leukemia: Partial Restoration with OKT3/IL-2 Activation.
37. Absidia Corymbiferain an immune competent accident victim with multiple abdominal injuries: case report
38. Hematopoietic Stem Cell Transplantation from Alternative Donors for High-Risk Acute Leukemia: The Haploidentical Option
39. Role of nerve growth factor and its receptors in non-nervous cancer growth: efficacy of a tyrosine kinase inhibitor (AG879) and neutralizing antibodies antityrosine kinase receptor A and antinerve growth factor: an in-vitro and in-vivo study
40. Hematopoietic Stem Cell Transplantation (HSCT) from Alternative Donors for Acute Leukemia at High-Risk of Relapse. The Haploidentical Option.
41. Interleukin 7-Engineered Stromal Cells: A New Approach for Hastening Naive T Cell Recruitment
42. Total body irradiation-based regimen in the conditioning of patients submitted to haploidentical stem cell transplantation
43. In Vivo Demethylation of a MoMuLV Retroviral Vector Expressing the Herpes Simplex Thymidine Kinase Suicide Gene by 5′ Azacytidine
44. Improved Outcome With T-Cell–Depleted Bone Marrow Transplantation for Acute Leukemia
45. Evaluation of immunotoxins containing single‐chain ribosome‐inactivating proteins and an anti‐CD22 monoclonal antibody (OM124):in vitroandin vivostudies
46. Anti‐CD30 (BER‐H2) immunotoxins containing the type‐1 ribosome‐inactivating proteins momordin and PAP‐S (pokeweed antiviral protein from seeds) display powerful antitumour activity against CD30 + tumour cells in vitro and in SCID mice
47. Host-vs-graft and graft-vs-host reactivity and immune reconstitution after T-depleted allogeneic bone marrow transplantation
48. Human T-helper clones induce IgG production in a subclass-specific fashion
49. Interleukin-6 is constitutively produced by human CTL clones and is required to maintain their cytolytic function
50. Activated autologous T cells exert an anti-B-cell chronic lymphatic leukemia effect in vitro and in vivo.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.